池田 悠至

医学部 医学科准教授

研究者情報

経歴

  • 2018年04月 - 現在
    日本大学医学部附属産婦人科学教室
  • 2018年04月01日
    日本大学医学部附属産婦人科学教室
  • 埼玉医科大学 医学部国際医療センター 産婦人科(婦人科腫瘍科), 助教
研究活動情報

論文

  • A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
    Vaccines (Basel), 2021年04月
  • High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
    J Gynecol Oncol, 2020年11月, 査読有り, 通常論文
  • Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate (MPA) in patients with grade 1 endometrioid adenocarcinoma
    Mol Clin Oncol, 2016年04月, 査読有り, 通常論文

MISC

  • Induction of Neoantigen-specific Cytotoxic T Cells and Construction of T-cell Receptor-engineered T cells for Ovarian Cancer
    Matsuda T; Leisegang M; Park JH et al
    Clin Cancer Res, 2018年12月01日, 査読有り, 通常論文
  • Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma
    Matsuo K; Takazawa Y; Ross MS et al
    Ann Surg Oncol, 2018年11月, 査読有り, 通常論文
  • Clinical utility of CA-125 in the management of uterine carcinosarcoma
    Matsuo K; Ross MS; Yunokawa M et al
    J Gynecol Oncol, 2018年11月, 査読有り, 通常論文
  • Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer
    Chuwa AH; Sone K; Oda K
    Oncol Lett, 2018年11月, 査読有り, 通常論文
  • Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.
    Matsuo K; Takazawa Y; Ross MS et al
    Ann Surg Oncol, 2018年09月, 査読有り, 通常論文
  • Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.
    Koji Matsuo; Yutaka Takazawa; Malcolm S Ross; Esther Elishaev; Mayu Yunokawa; Todd B Sheridan; Stephen H Bush; Merieme M Klobocista; Erin A Blake; Tadao Takano; Tsukasa Baba; Shinya Satoh; Masako Shida; Yuji Ikeda; Sosuke Adachi; Takuhei Yokoyama; Munetaka Takekuma; Shiori Yanai; Satoshi Takeuchi; Masato Nishimura; Keita Iwasaki; Marian S Johnson; Masayuki Yoshida; Ardeshir Hakam; Hiroko Machida; Paulette Mhawech-Fauceglia; Yutaka Ueda; Kiyoshi Yoshino; Hiroshi Kajiwara; Kosei Hasegawa; Masanori Yasuda; Takahito M Miyake; Takuya Moriya; Yoshiaki Yuba; Terry Morgan; Tomoyuki Fukagawa; Tanja Pejovic; Tadayoshi Nagano; Takeshi Sasaki; Abby M Richmond; Miriam D Post; Mian M K Shahzad; Dwight D Im; Hiroshi Yoshida; Kohei Omatsu; Frederick R Ueland; Joseph L Kelley; Rouzan G Karabakhtsian; Lynda D Roman
    Surgical oncology, 2018年09月, 査読有り, 通常論文
  • The era of immunogenomics/immunopharmacogenomicsrget
    Zewde M; Kiyotani K; Park JH et al
    J Hum Genet, 2018年07月, 査読有り, 通常論文
  • Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery
    Matsuo K; Johnson MS; Im DD et al
    J Surg Oncol, 2018年03月, 査読有り, 通常論文
  • Significance of venous thromboembolism in women with uterine carcinosarcoma
    Koji Matsuo; Malcolm S. Ross; Dwight D. Im; Merieme M. Klobocista; Stephen H. Bush; Marian S. Johnson; Tadao Takano; Erin A. Blake; Yuji Ikeda; Masato Nishimura; Yutaka Ueda; Masako Shida; Kosei Hasegawa; Tsukasa Baba; Sosuke Adachi; Takuhei Yokoyama; Shinya Satoh; Hiroko Machida; Shiori Yanai; Keita Iwasaki; Takahito M. Miyake; Satoshi Takeuchi; Munetaka Takekuma; Tadayoshi Nagano; Mayu Yunokawa; Tanja Pejovic; Kohei Omatsu; Mian M.K. Shahzad; Joseph L. Kelley; Frederick R. Ueland; Lynda D. Roman
    Gynecologic Oncology, 2018年02月01日, 査読有り, 通常論文
  • A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer
    Yano M; Ikeda Y; Kato T et al
    Mol Clin Oncol, 2018年02月, 査読有り, 通常論文
  • Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells
    Taigo Kato; Tatsuo Matsuda; Yuji Ikeda; Jae-Hyun Park; Matthias Leisegang; Sachiko Yoshimura; Tetsuro Hikichi; Makiko Harada; Makda Zewde; Sho Sato; Kosei Hasegawa; Kazuma Kiyotani; Yusuke Nakamura
    Oncotarget, 2018年, 査読有り, 通常論文
  • Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer
    Kosei Hasegawa; Yuji Ikeda; Yuko Kunugi; Akira Kurosaki; Yuichi Imai; Shunsuke Kohyama; Shoji Nagao; Eito Kozawa; Koji Yoshida; Takuya Tsunoda; Yusuke Nakamura; Keiichi Fujiwara
    Journal of Immunotherapy, 2018年, 査読有り, 通常論文
  • Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma
    Matsuo K; Ross MS; Yunokawa M et al
    Gynecol Oncol, 2017年12月, 査読有り, 通常論文
  • Characterization of the tumor T-cell receptor repertoire and immune microenvironment in patients with locoregionally advanced squamous cell carcinoma of the head and neck
    Saloura V; Fatima A; Zewde M et al
    Clin Cancer Res, 2017年08月15日, 査読有り, 通常論文
  • Characterization of the cryoablation-induced immune response in kidney cancer patients
    Kato T; Iwasaki T; Uemura M et al
    Oncoimmunology, 2017年05月16日, 査読有り, 通常論文
  • Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer
    Yuji Ikeda; Kazuma Kiyotani; Poh Yin Yew; Sho Sato; Yuichi Imai; Rui Yamaguchi; Satoru Miyano; Keiichi Fujiwara; Kosei Hasegawa; Yusuke Nakamura
    ONCOLOGY REPORTS, 2017年05月, 査読有り, 通常論文
  • Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma
    Koji Matsuo; Kohei Omatsu; Malcolm S. Ross; Marian S. Johnson; Mayu Yunokawa; Merieme M. Klobocista; Dwight D. Im; Stephen H. Bush; Yutaka Ueda; Tadao Takano; Erin A. Blake; Kosei Hasegawa; Tsukasa Baba; Masako Shida; Shinya Satoh; Takuhei Yokoyama; Hiroko Machida; Sosuke Adachi; Yuji Ikeda; Keita Iwasaki; Takahito M. Miyake; Shiori Yanai; Masato Nishimura; Tadayoshi Nagano; Munetaka Takekuma; Satoshi Takeuchi; Tanja Pejovic; Mian Mk Shahzad; Frederick R. Ueland; Joseph L. Kelley; Lynda D. Roman
    GYNECOLOGIC ONCOLOGY, 2017年04月, 査読有り, 通常論文
  • Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma
    Koji Matsuo; Malcolm S. Ross; Stephen H. Bush; Mayu Yunokawa; Erin A. Blake; Tadao Takano; Yutaka Ueda; Tsukasa Baba; Shinya Satoh; Masako Shida; Yuji Ikeda; Sosuke Adachi; Takuhei Yokoyama; Munetaka Takekuma; Satoshi Takeuchi; Masato Nishimura; Keita Iwasaki; Shiori Yanai; Merieme M. Klobocista; Marian S. Johnson; Hiroko Machida; Kosei Hasegawa; Takahito M. Miyake; Tadayoshi Nagano; Tanja Pejovic; Mian M. K. Shahzad; Dwight D. Im; Kohei Omatsu; Frederick R. Ueland; Joseph L. Kelley; Lynda D. Roman
    GYNECOLOGIC ONCOLOGY, 2017年02月, 査読有り, 通常論文
  • Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers
    Kato T; Park JH; Kiyotani K et al
    Oncotarget, 2017年01月28日, 査読有り, 通常論文
  • The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma
    Matsushita H; Hasegawa K; Oda K et al
    Oncoimmunology, 2017年01月16日, 査読有り, 通常論文
  • Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
    Shinya Oki; Kenbun Sone; Katsutoshi Oda; Ryuji Hamamoto; Masako Ikemura; Daichi Maeda; Makoto Takeuchi; Michihiro Tanikawa; Mayuyo Mori-Uchino; Kazunori Nagasaka; Aki Miyasaka; Tomoko Kashiyama; Yuji Ikeda; Takahide Arimoto; Hiroyuki Kuramoto; Osamu Wada-Hiraike; Kei Kawana; Masashi Fukayama; Yutaka Osuga; Tomoyuki Fujii
    Oncotarget, 2017年, 査読有り, 通常論文
  • T-LAK cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in ovarian cancer
    Ikeda Y; Park JH; Miyamoto T
    Clin Can Res, 2016年12月15日, 査読有り, 通常論文
    筆頭著者
  • Autophagy inhibition augments resveratrol‑induced apoptosis in Ishikawa endometrial cancer cells
    Fukuda T; Oda K; Wada-Hiraike O
    Oncol Lett, 2016年10月, 査読有り, 通常論文
  • Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma
    Matsuo K; Takazawa Y; Ross MS et al
    Ann Oncol, 2016年07月, 査読有り, 通常論文
  • Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecological malignancies
    Oda K; Ikeda Y; Kashiyama T et al
    J Obstet Gynaecol Res, 2016年07月, 査読有り, 通常論文
  • Perspectives of personalized medicine targeting PI3K pathway in endometrial and ovarian cancer
    Oda K; Ikeda Y; Kashiyama T et al
    Personalized Medicine Universe, 2016年07月, 査読有り, 通常論文
  • Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging
    Kanako Inaba; Katsutoshi Oda; Kazuhiro Aoki; Kenbun Sone; Yuji Ikeda; Aki Miyasaka; Tomoko Kashiyama; Tomohiko Fukuda; Chinami Makii; Takahide Arimoto; Osamu Wada-Hiraike; Kei Kawana; Tetsu Yano; Yutaka Osuga; Tomoyuki Fujii
    ONCOTARGET, 2016年05月, 査読有り, 通常論文
  • Practice patterns of adjuvant therapy for intermediate/high recurrence risk adjuvant therapy for patients in Japan
    Ikeda Y; Furusawa A; Kitagawa R et al
    J Gynecol Oncol, 2016年05月, 査読有り, 通常論文
    筆頭著者
  • Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate (MPA) in patients with grade 1 endometrioid adenocarcinoma
    Sato M; Arimoto T; Kawana K et al
    Mol Clin Oncol, 2016年04月, 査読有り, 通常論文
  • Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients
    Tsuruga T; Fujimoto A; Kawana K; et al
    Int J Clin Oncol, 2016年03月, 査読有り, 通常論文
  • Germline PARP4 mutations in patients with primary thyroid and breast cancers
    Yuji Ikeda; Kazuma Kiyotani; Poh Yin Yew; Taigo Kato; Kenji Tamura; Kai Lee Yap; Sarah M. Nielsen; Jessica L. Mester; Charis Eng; Yusuke Nakamura; Raymon H. Grogan
    ENDOCRINE-RELATED CANCER, 2016年03月, 査読有り, 通常論文
  • Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer
    Chuwa AH; Sone K; Oda K
    Gynecol Oncol, 2016年01月, 査読有り, 通常論文
  • MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53
    Chinami Makii; Katsutoshi Oda; Yuji Ikeda; Kenbun Sone; Kosei Hasegawa; Yuriko Uehara; Akira Nishijima; Kayo Asada; Takahiro Koso; Tomohiko Fukuda; Kanako Inaba; Shinya Oki; Hidenori Machino; Machiko Kojima; Tomoko Kashiyama; Mayuyo Mori-Uchino; Takahide Arimoto; Osamu Wada-Hiraike; Kei Kawana; Tetsu Yano; Keiichi Fujiwara; Hiroyuki Aburatani; Yutaka Osuga; Tomoyuki Fujii
    Oncotarget, 2016年, 査読有り, 通常論文